159 related articles for article (PubMed ID: 26884913)
1. Overexpression of STAT3/pSTAT3 was associated with poor prognosis in gastric cancer: a meta-analysis.
He S; Liao G; Liu Y; Huang L; Kang M; Chen L
Int J Clin Exp Med; 2015; 8(11):20014-23. PubMed ID: 26884913
[TBL] [Abstract][Full Text] [Related]
2. The prognostic value of pSTAT3 in gastric cancer: a meta-analysis.
Yu S; Li G; Wang Z; Wang Z; Chen C; Cai S; He Y
J Cancer Res Clin Oncol; 2016 Mar; 142(3):649-57. PubMed ID: 26233579
[TBL] [Abstract][Full Text] [Related]
3. Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
Lee J; Kang WK; Park JO; Park SH; Park YS; Lim HY; Kim J; Kong J; Choi MG; Sohn TS; Noh JH; Bae JM; Kim S; Lim DH; Kim KM; Park CK
APMIS; 2009 Aug; 117(8):598-606. PubMed ID: 19664131
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of sphingosine-1-phosphate receptor 1 and phospho-signal transducer and activator of transcription 3 is associated with poor prognosis in rituximab-treated diffuse large B-cell lymphomas.
Paik JH; Nam SJ; Kim TM; Heo DS; Kim CW; Jeon YK
BMC Cancer; 2014 Dec; 14():911. PubMed ID: 25472725
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Value and Clinicopathological Significance of p-stat3 Among Gastric Carcinoma Patients: A Systematic Review and Meta-Analysis.
Ji K; Zhang L; Zhang M; Chu Q; Li X; Wang W
Medicine (Baltimore); 2016 Feb; 95(5):e2641. PubMed ID: 26844481
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts.
Aleskandarany MA; Agarwal D; Negm OH; Ball G; Elmouna A; Ashankyty I; Nuglozeh E; Fazaludeen MF; Diez-Rodriguez M; Nolan CC; Tighe PJ; Green AR; Ellis IO; Rakha EA
Breast Cancer Res Treat; 2016 Feb; 156(1):9-20. PubMed ID: 26907764
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of SMYD3 was associated with increased STAT3 activation in gastric cancer.
Liu Y; Deng J; Luo X; Pan Y; Zhang L; Zhang R; Liang H
Med Oncol; 2015 Jan; 32(1):404. PubMed ID: 25471787
[TBL] [Abstract][Full Text] [Related]
9. Kynurenine 3-monooxygenase (KMO), and signal transducer and activator of transcription 3 (STAT3) expression is involved in tumour proliferation and predicts poor survival in canine melanoma.
Liu IL; Chung TF; Huang WH; Hsu CH; Liu CC; Chiu YH; Huang KC; Liao AT; Lin CS
Vet Comp Oncol; 2021 Mar; 19(1):79-91. PubMed ID: 32720434
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis.
Li MX; Bi XY; Huang Z; Zhao JJ; Han Y; Li ZY; Zhang YF; Li Y; Chen X; Hu XH; Zhao H; Cai JQ
PLoS One; 2015; 10(5):e0127356. PubMed ID: 26024373
[TBL] [Abstract][Full Text] [Related]
11. The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis.
Rosen DG; Mercado-Uribe I; Yang G; Bast RC; Amin HM; Lai R; Liu J
Cancer; 2006 Dec; 107(11):2730-40. PubMed ID: 17063503
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with breast cancer.
Liu Y; Huang J; Li W; Chen Y; Liu X; Wang J
Oncotarget; 2018 Feb; 9(16):13060-13067. PubMed ID: 29560131
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and clinical significance of STAT3 and MMP9 in patients with gastric cancer: a meta-analysis of a Chinese cohort.
Chen J; Liu X; Jiao H; Peng L; Huo Z; Yang W; Shen Q; Li T; Liu Q
Int J Clin Exp Med; 2015; 8(1):546-57. PubMed ID: 25785029
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of phosphorylated signal transducer and activator of transcription 3 and suppressor of cytokine signaling 3 expression in human cutaneous melanoma.
Wu ZS; Cheng XW; Wang XN; Song NJ
Melanoma Res; 2011 Dec; 21(6):483-90. PubMed ID: 21876460
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
[TBL] [Abstract][Full Text] [Related]
16. Correlation between p-STAT3 overexpression and prognosis in lung cancer: A systematic review and meta-analysis.
Tong M; Wang J; Jiang N; Pan H; Li D
PLoS One; 2017; 12(8):e0182282. PubMed ID: 28797050
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Values of LAPTM4B-35 in Human Cancer: A Meta-analysis.
Zhou L; Dai C; Tian T; Wang M; Lin S; Deng Y; Xu P; Hao Q; Wu Y; Yang T; Zhu W; Dai Z
J Cancer; 2018; 9(23):4355-4362. PubMed ID: 30519340
[No Abstract] [Full Text] [Related]
18. The Role of p-STAT3 as a Prognostic and Clinicopathological Marker in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ji K; Zhang M; Chu Q; Gan Y; Ren H; Zhang L; Wang L; Li X; Wang W
PLoS One; 2016; 11(8):e0160125. PubMed ID: 27504822
[TBL] [Abstract][Full Text] [Related]
19. Patient Characteristics Influence Activated Signal Transducer and Activator of Transcription 3 (STAT3) Levels in Primary Breast Cancer-Impact on Prognosis.
Nilsson L; Sandén E; Khazaei S; Tryggvadottir H; Nodin B; Jirström K; Borgquist S; Isaksson K; Jernström H
Front Oncol; 2020; 10():1278. PubMed ID: 32850390
[No Abstract] [Full Text] [Related]
20. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
Jensen TO; Schmidt H; Møller HJ; Donskov F; Høyer M; Sjoegren P; Christensen IJ; Steiniche T
Cancer; 2012 May; 118(9):2476-85. PubMed ID: 21953023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]